Picture Swiss Biotech Association LSE Global Village 2025 Basel 650x100px

Product › Details

ESM™ technology (Esterase Sensitive Motif technology)

	Next higher product group	drug delivery technology_oo
	Status	2017-01-09 development existent
	Organisation	Macrophage Pharma Ltd. (MPL)
	Organisation 2	Chroma Therapeutics Ltd.

Record changed: 2023-07-10

Picture Swiss Biotech Association LSE Swiss Biotech Days 2025 Basel 650x200px

More documents for drug delivery technology_oo

[1] Ryvu Therapeutics S.A.. (10/29/24). "Press Release: Ryvu Therapeutics to Collaborate with nCage Therapeutics on the Development of a Next-Generation ADC Platform". Krakow....
[2] Cosmo Pharmaceuticals N.V.. (10/11/24). "Press Release: Cosmo Pharmaceuticals Appoints New Chief Financial Officer". Dublin....
[3] Cosmo Pharmaceuticals N.V.. (9/23/24). "Press Release: Cosmo Pharmaceuticals Enhances Management Team with Newly Appointed Head of Global Business Development". Dublin....
[4] Cosmo Pharmaceuticals N.V.. (4/25/24). "Press Release (Ad hoc): Cosmo Announces Leadership Changes. Giovanni Di Napoli Appointed as New CEO Effective from 24 May 2024.". Dublin....
[5] ViaNautis Bio Ltd.. (11/13/23). "Press Release: ViaNautis Bio Announces $25 Million Series A Financing to Drive the Next Generation of Genetic Nanomedicines". Cambridge....
[6] Circio Holding ASA. (10/10/23). "Press Release: Circio and Neoregen Biotech Enter Collaboration for Delivery of Novel Circular RNA Therapeutics Using NICT technology"....
[7] Lidds AB. (7/15/22). "Press Release: Lidds AB (publ) Announces the Appointment of Anders Månsson as CEO". Uppsala....
[8] Pancryos ApS. (5/24/22). "Press Release: Pancryos Announces Exclusive Global License Agreement for First in Class Macroencapsulation Device". Copenhagen....
[9] Gennao Bio. (5/10/22). "Press Release: Gennao Bio Closes $40 Million Series A Financing to Develop Pipeline of Targeted Nucleic Acid Therapeutics". New Haven, CT....
[10] Marinomed Biotech AG. (2/15/22). "Press Release: Marinomed Receives €6m with Final Tranche of Financing Agreement with EIB to Invest in Proprietary R&D Pipeline". Korneuburg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]